OBOnur Büyüktekeli

Onur Büyüktekeli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Onur Büyüktekeli has a total of 2 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Investigation of Uric Acid/HDL-Cholesterol Ratio as an Independent Risk Factor for Diabetic Nephropathy: A Cross-Sectional Study

    by Zekeriya Keskin, Onur Büyüktekeli, Muhammed Faruk Aşkın

    Diabetic nephropathy (DN) is a major microvascular complication requiring early markers for risk stratification. We investigated the clinical utility of the uric acid (UA) to high density lipoprotein cholesterol (HDL-C) ratio (UHR) as a practical proinflammatory-prooxidative marker for DN. In this retrospective cross-sectional study, records of 934 patients with diabetes mellitus (DM) were analyzed. UHR was calculated as [UA/HDL] x 100. DN was defined based on the albumin-to-creatinine ratio (ACR) and/or estimated glomerular filtration rate (eGFR) criteria. Patients were evaluated according to the presence of nephropathy, stage of nephropathy, and albuminuria categories. ROC analysis was performed for UHR, UA and HDL-C. Factors associated with DN were evaluated using logistic regression analysis. UHR was significantly higher in patients with DN compared to those without DN (p

  • Evaluation of artificial intelligence chatbots in answering questions about unintentional weight loss: a comparative study

    by Zekeriya Keskin, Muhammed Faruk Aşkın, Onur Büyüktekeli

    Aim Our study aims to evaluate the accuracy comparatively reliability of the responses provided by artificial intelligence (AI) chatbots ChatGPT, DeepSeek, and Gemini to clinical questions regarding a symptom with a multidisciplinary and broad differential diagnosis, such as unintentional weight loss (UWL). Methods 129 clinical questions, definitions, symptomatology, differential diagnosis, diagnostic approach, treatment and management, and patient questions compiled from various health websites, books, and guides were categorized under six main headings and directed to three different AI chatbots. Each chatbot was asked to score the difficulty level of each question, and the relationship between difficulty assessments and accuracy performance was analyzed. Each response was evaluated by three internal medicine specialists and scored 1–4 based on accuracy. Results ChatGPT and DeepSeek demonstrated similar performance with high accuracy rates, while Gemini performed at a significantly lower accuracy level. Significant differences were observed between the chatbots in five of the six question groups (p0.05). Conclusion While ChatGPT and DeepSeek offer high accuracy and reliability, Gemini has performed below these two AI chatbots. Our findings indicate that AI chatbots should not be used as standalone tools for diagnosis, treatment, and management in complex clinical decision-making processes. However, they can be considered an important complementary tool for rapid access to accurate information and supporting clinical decisions.